Sunil Healthcare Ratios

Sunil Healthcare Ltd Ratios

The Sunil Healthcare Ltd Ratios page provides a complete fundamental analysis of Sunil Healthcare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Sunil Healthcare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Sunil Healthcare Ltd (NSE: , BSE: 537253) is currently trading at ₹61.97, with a market capitalization of ₹635.49M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Sunil Healthcare Ltd remains a key stock for fundamental analysis using Sunil Healthcare Ltd Ratios.

Sunil Healthcare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Sunil Healthcare Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Sunil Healthcare Ltd Ratios.

Historically, the Sunil Healthcare Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 8.75
• 2021: 11.37
• 2020: 0

The decline in Sunil Healthcare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Sunil Healthcare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.

Historical P/B trend:

• 2024: 1
• 2023: 0.93
• 2022: 1.04
• 2021: 1.46

Sunil Healthcare Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Sunil Healthcare Ltd P/S ratio currently stands at 0.81, an important part of Sunil Healthcare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.81
• 2023: 0.70
• 2022: 0.53
• 2021: 0.61

The rising Sunil Healthcare Ltd P/S ratio indicates improved revenue valuation by investors.

Sunil Healthcare Ltd Price to Cash Flow Ratio (P/CF)

The Sunil Healthcare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 12.04.

Historical Sunil Healthcare Ltd Price to Cash Flow Ratio:

• 2024: 12.04
• 2023: 0
• 2022: 15.98
• 2021: 3.77
• 2020: 2.07

The rising Sunil Healthcare Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Sunil Healthcare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Sunil Healthcare Ltd EV currently stands at ₹1.33B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 1.33B
• 2023: 1.26B
• 2022: 913.36M
• 2021: 1.04B

Sunil Healthcare Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Sunil Healthcare Ltd EV/EBITDA ratio is currently 11.16, a key metric in Sunil Healthcare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 11.16
• 2023: 28.78
• 2022: 5.66
• 2021: 5.96

Stable Sunil Healthcare Ltd EV/EBITDA indicates balanced valuation.

Sunil Healthcare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Sunil Healthcare Ltd D/E ratio is currently 1.02, reflecting leverage and financial stability.

Historical D/E:

• 2024: 1.02
• 2023: 0.97
• 2022: 0.66
• 2021: 0.69

Higher D/E ratio indicates rising financial risk.

Return on Equity (ROE %)

The Sunil Healthcare Ltd ROE currently stands at -2.09%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -2.09
• 2023: -2.88
• 2022: 12.61
• 2021: 13.71

Declining ROE indicates pressure on profitability.

Sunil Healthcare Ltd Ratios Analysis Summary

The Sunil Healthcare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Sunil Healthcare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Sunil Healthcare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.